Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Permanent prostate brachytherapy: lessons learned, lessons to learn.

L Potters1

  • 1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. PottersL@mskcc.org

Oncology (Williston Park, N.Y.)
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.

Radiation oncology (London, England)·2015
Same author

Permanent prostate brachytherapy: a century of technical evolution.

Prostate cancer and prostatic diseases·2006
Same author

The role of external radiotherapy in patients treated with permanent prostate brachytherapy.

Prostate cancer and prostatic diseases·2004
Same author

Permanent prostate brachytherapy in men with clinically localised prostate cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2003
Same author

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.

Urology·2001
Same author

Potency after permanent prostate brachytherapy for localized prostate cancer.

International journal of radiation oncology, biology, physics·2001

Permanent prostate brachytherapy offers excellent long-term results for localized prostate cancer, comparable to surgery or external radiation. Further research is needed to define optimal patient selection and treatment protocols for this effective therapy.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urology

Background:

  • Permanent prostate brachytherapy demonstrates excellent biochemical control for localized prostate cancer.
  • Long-term (5-10 year) outcomes are comparable to external-beam irradiation and radical prostatectomy.
  • Variations in treatment protocols and patient selection exist, with ongoing debate regarding monotherapy versus combination therapy.

Purpose of the Study:

  • To analyze the role of isotope selection, external-beam irradiation, and neoadjuvant androgen deprivation in permanent prostate brachytherapy.
  • To provide insights into optimizing permanent brachytherapy techniques for localized prostate cancer.
  • To emphasize the importance of postimplant dosimetry and explore criteria for evaluating implant quality.

Main Methods:

Related Experiment Videos

  • Matched-pair analysis studies were conducted.
  • Evaluation of isotope selection, combination with external-beam irradiation, and neoadjuvant androgen deprivation.
  • Investigation of computed tomography (CT)-based criteria for implant quality and dose assessment.

    • Main Results:

    • Permanent prostate brachytherapy shows comparable 5- to 10-year results to other treatment modalities.
    • Studies provide insights into the use of permanent brachytherapy, including isotope choice and adjunct therapies.
    • CT-based criteria show promise for evaluating implant quality, though prostate edema and imaging limitations pose challenges.

    Conclusions:

    • Permanent prostate brachytherapy is a viable treatment option with excellent long-term outcomes for localized prostate cancer.
    • Further standardization of treatment protocols and patient selection is warranted.
    • Advancements in imaging and treatment planning are crucial for improving postimplant dosimetry and procedure outcomes.